Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Agitation in Patients With Dementia of the Alzheimer's Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00012857
What this trial is testing

Pain Management and Behavioral Outcomes in Patients With Dementia

Who this might be right for
DementiaAlzheimer Disease, PainBehavior, Agitation
US Department of Veterans Affairs 66
Large-scale testing (Phase 3)Study completedNCT03620981
What this trial is testing

Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 410
Large-scale testing (Phase 3)Ended earlyNCT06736509
What this trial is testing

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 139
Large-scale testing (Phase 3)Ended earlyNCT02446132
What this trial is testing

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,197
Not applicableStudy completedNCT02686190
What this trial is testing

Effects of Light-therapy in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Assistance Publique - Hôpitaux de Paris 91
Not applicableUnknownNCT00703430
What this trial is testing

Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Peking University 50
Testing effectiveness (Phase 2)Ended earlyNCT01766336
What this trial is testing

A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 296
Large-scale testing (Phase 3)Study completedNCT05557409
What this trial is testing

Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation
Axsome Therapeutics, Inc. 408
Not applicableStudy completedNCT00015548
What this trial is testing

CATIE-Alzheimer's Disease Trial

Who this might be right for
Alzheimer's Disease
National Institute of Mental Health (NIMH) 450
Testing effectiveness (Phase 2)UnknownNCT05239390
What this trial is testing

SCI-110 for Alzheimer Disease and Agitation

Who this might be right for
Alzheimer Disease
The Israeli Medical Center for Alzheimer's 20
Not applicableUnknownNCT02147652
What this trial is testing

Personalized Music Therapy and Agitation in Dementia

Who this might be right for
Alzheimer's DiseaseVascular Dementia
University Health Network, Toronto 60
Not applicableStudy completedNCT01329536
What this trial is testing

The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseAgitation
Avera McKennan Hospital & University Health Center 50
Large-scale testing (Phase 3)Ended earlyNCT02168920
What this trial is testing

Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Co., Ltd. 150
Large-scale testing (Phase 3)Ended earlyNCT02817906
What this trial is testing

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Who this might be right for
Agitation in Dementia, Including Alzheimer's Disease
Intra-Cellular Therapies, Inc. 177
Large-scale testing (Phase 3)Study completedNCT03393520
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 601
Large-scale testing (Phase 3)Study completedNCT02442778
What this trial is testing

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Participants With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 522